Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Oral‑fluid prescription‑compliance testing remains unproven; $500,000 line untouched after no bids on RFP
Summary
Court officials told the appropriations subcommittee that a $500,000 multi‑year boilerplate for oral‑fluid prescription‑compliance testing remains unspent; tests over three years showed oral swabs detect presence of drugs but cannot reliably determine dosage or compliance with treatment‑court orders, and an RFP to evaluate the method attracted no
State Court Administrator Tom Boyd told the House Appropriations Subcommittee that the judiciary's multi‑year budget boilerplate to study oral‑fluid prescription‑compliance testing has not been spent and that, while initial testing demonstrated oral‑fluid swabs detect specific drugs, the method so far cannot determine compliance with treatment‑court orders that require taking the correct dose.
"None of that money's been used at all," Boyd said of the $500,000 item created in last year’s budget. He described three years of pilot testing showing oral‑fluid swabs can detect the presence of certain prescription drugs but said the tests cannot reliably measure how much of a drug a person took or whether a person followed dosage instructions — the…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
